An RNA foundation model enables discovery of disease mechanisms and candidate therapeutics
Celaj, A.; Gao, A. J.; Lau, T. T. Y.; Holgersen, E. M.; Lo, A.; Lodaya, V.; Cole, C. B.; Denroche, R. E.; Spickett, C.; Wagih, O.; Pinheiro, P. O.; Vora, P.; Mohammadi-Shemirani, P.; Chan, S.; Nussbaum, Z.; Zhang, X.; Zhu, H.; Ramamurthy, E.; Kanuparthi, B.; Iacocca, M.; Ly, D.; Kron, K.; Verby, M.; Cheung-Ong, K.; Shalev, Z.; Vaz, B.; Bhargava, S.; Yusuf, F.; Samuel, S.; Alibai, S.; Baghestani, Z.; He, X.; Krastel, K.; Oladapo, O.; Mohan, A.; Shanavas, A.; Bugno, M.; Bogojeski, J.; Schmitges, F.; Kim, C.; Grant, S.; Jayaraman, R.; Masud, T.; Deshwar, A.; Gandhi, S.; Frey, B. J.
Show abstract
Accurately modeling and predicting RNA biology has been a long-standing challenge, bearing significant clinical ramifications for variant interpretation and the formulation of tailored therapeutics. We describe a foundation model for RNA biology, "BigRNA", which was trained on thousands of genome-matched datasets to predict tissue-specific RNA expression, splicing, microRNA sites, and RNA binding protein specificity from DNA sequence. Unlike approaches that are restricted to missense variants, BigRNA can identify pathogenic non-coding variant effects across diverse mechanisms, including polyadenylation, exon skipping and intron retention. BigRNA accurately predicted the effects of steric blocking oligonucleotides (SBOs) on increasing the expression of 4 out of 4 genes, and on splicing for 18 out of 18 exons across 14 genes, including those involved in Wilson disease and spinal muscular atrophy. We anticipate that BigRNA and foundation models like it will have widespread applications in the field of personalized RNA therapeutics.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification and analysis of splicing quantitative trait loci across multiple tissues in the human genome 97%
- G4mer: An RNA language model for transcriptome-wide identification of G-quadruplexes and disease variants from population-scale genetic data 97%
- Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2 97%
Similar papers in this journal
Similar papers in this journal
- Linking regulatory variants to target genes by integrating single-cell multiome methods and genomic distance 97%
- Dynamic network-guided CRISPRi screen reveals CTCF loop-constrained nonlinear enhancer-gene regulatory activity in cell state transitions 96%
- Benchmarking of deep neural networks for predicting personal gene expression from DNA sequence highlights shortcomings 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.